Herve Tilly (Hervé Tilly)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Structural Basis

Hodgkin Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Eva Hoster, Marie-Hélène Delfau-Larue, Elizabeth Macintyre, Linmiao Jiang, Stephan Stilgenbauer, Ursula Vehling-Kaiser, Gilles Andre Salles, Catherine Thieblemont, Herve Tilly, Stefan Wirths, Pierre Feugier, Kai Hübel, Christian Schmidt, Vincent Ribrag, Hanneke C Kluin-Nelemans, Martin Dreyling, Christiane Pott, null null
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Guillaume Cartron, Emmanuel Bachy, Herve Tilly, Nicolas Daguindau, Gian-Matteo Pica, Fontanet Bijou, Christiane Mounier, Aline Clavert, Gandhi Laurent Damaj, Borhane Slama, René-Olivier Casasnovas, Houot Roch, Krimo Bouabdallah, David Sibon, Olivier Fitoussi, Nadine Morineau, Charles Herbaux, Thomas Gastinne, Luc-Matthieu Fornecker, Corinne Haioun, Vincent Launay, Carla Araujo, Omar Benbrahim, Laurence Sanhes, Remy Gressin, Hugo Gonzalez, Judith Trotman, David Ternant, Luc Xerri, Karin Tarte, Delphine Pranger
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Pier Luigi Luigi Zinzani, Jiří Mayer, Christopher R Flowers, Fontanet Bijou, Ana C Oliveira, Yuqin Song, Qingyuan Zhang, Michele Merli, Krimo Bouabdallah, Peter Ganly, Huilai Zhang, Roderick Johnson, Alejandro Martin Martin Garcia-Sancho, Mariano Provencio Pulla, Marek Trněný, Sam Yuen, Herve Tilly, Edwin Kingsley, Gayane Tumyan, Sarit E Assouline, Rebecca Auer, Elena Ivanova, Pil Kim, Sha Huang, Richard Delarue, Judith Trotman
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sarah Bailly, Guillaume Cartron, Sridhar Chaganti, Raul Cordoba, Paolo Corradini, Johannes Düll, Isacco Ferrarini, Wendy Osborne, Andreas Rosenwald, Juan-Manuel Sancho, Herve Tilly, Eric Van Den Neste, Andreas Viardot, Chiara Rusconi
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper. Hematological oncology 40 (4) (2022)
Vincent Camus, Herve Tilly
Polatuzumab vedotin, an anti-CD79b antibody-drug conjugate for the treatment of relapsed/refractory diffuse large B-cell lymphoma. Future oncology (London, England) 17 (2) (2020)